Aptorum Group Ltd Net Income
| APM Stock | USD 0.78 0.07 8.24% |
As of the 14th of February 2026, Aptorum Group shows the Mean Deviation of 3.72, risk adjusted performance of (0.11), and Standard Deviation of 5.27. Aptorum Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Aptorum Group market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Aptorum Group is priced correctly, providing market reflects its regular price of 0.78 per share. As Aptorum Group is a penny stock we also strongly suggest to validate its jensen alpha numbers.
Aptorum Group Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 31.2197 | Earnings Share (0.31) | Quarterly Revenue Growth (1.00) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -3.7 M | -3.9 M | |
| Net Loss | -22.5 M | -21.4 M | |
| Net Loss | -3.8 M | -4 M | |
| Net Loss | (0.70) | (0.74) | |
| Net Income Per E B T | 1.18 | 1.07 |
Aptorum | Net Income | Build AI portfolio with Aptorum Stock |
Evaluating Aptorum Group's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Aptorum Group Ltd's fundamental strength.
Latest Aptorum Group's Net Income Growth Pattern
Below is the plot of the Net Income of Aptorum Group Ltd over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Aptorum Group financial statement analysis. It represents the amount of money remaining after all of Aptorum Group Ltd operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Aptorum Group's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptorum Group's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (4.27 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Aptorum Net Income Regression Statistics
| Arithmetic Mean | (5,515,063) | |
| Geometric Mean | 4,239,566 | |
| Coefficient Of Variation | (137.58) | |
| Mean Deviation | 5,447,853 | |
| Median | (2,547,000) | |
| Standard Deviation | 7,587,429 | |
| Sample Variance | 57.6T | |
| Range | 32.1M | |
| R-Value | (0.23) | |
| Mean Square Error | 58.2T | |
| R-Squared | 0.05 | |
| Significance | 0.38 | |
| Slope | (344,435) | |
| Total Sum of Squares | 921.1T |
Aptorum Net Income History
Other Fundumenentals of Aptorum Group
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Aptorum Group Net Income component correlations
Aptorum Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Aptorum Group is extremely important. It helps to project a fair market value of Aptorum Stock properly, considering its historical fundamentals such as Net Income. Since Aptorum Group's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Aptorum Group's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Aptorum Group's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Aptorum diversify its offerings? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aptorum Group data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Aptorum Group's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aptorum Group represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Aptorum Group's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Aptorum Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aptorum Group's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aptorum Group.
| 11/16/2025 |
| 02/14/2026 |
If you would invest 0.00 in Aptorum Group on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Aptorum Group Ltd or generate 0.0% return on investment in Aptorum Group over 90 days. Aptorum Group is related to or competes with Marker Therapeutics, Mustang Bio, Cingulate, Cellectar Biosciences, Immuron, AEON Biopharma, and Bolt Biotherapeutics. Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of ther... More
Aptorum Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aptorum Group's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aptorum Group Ltd upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 28.25 | |||
| Value At Risk | (10.53) | |||
| Potential Upside | 5.51 |
Aptorum Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aptorum Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aptorum Group's standard deviation. In reality, there are many statistical measures that can use Aptorum Group historical prices to predict the future Aptorum Group's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.15) | |||
| Treynor Ratio | (1.55) |
Aptorum Group February 14, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (1.54) | |||
| Mean Deviation | 3.72 | |||
| Coefficient Of Variation | (706.09) | |||
| Standard Deviation | 5.27 | |||
| Variance | 27.79 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.79) | |||
| Total Risk Alpha | (1.15) | |||
| Treynor Ratio | (1.55) | |||
| Maximum Drawdown | 28.25 | |||
| Value At Risk | (10.53) | |||
| Potential Upside | 5.51 | |||
| Skewness | 0.609 | |||
| Kurtosis | 2.55 |
Aptorum Group Backtested Returns
Aptorum Group secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of risk over the last 3 months. Aptorum Group Ltd exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aptorum Group's Risk Adjusted Performance of (0.11), standard deviation of 5.27, and Mean Deviation of 3.72 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.49, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Aptorum Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aptorum Group is expected to be smaller as well. At this point, Aptorum Group has a negative expected return of -0.75%. Please make sure to confirm Aptorum Group's skewness, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Aptorum Group performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.76 |
Good predictability
Aptorum Group Ltd has good predictability. Overlapping area represents the amount of predictability between Aptorum Group time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aptorum Group price movement. The serial correlation of 0.76 indicates that around 76.0% of current Aptorum Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.76 | |
| Spearman Rank Test | 0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Aptorum Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Aptorum Group Ltd reported net income of (4.27 Million). This is 101.25% lower than that of the Biotechnology sector and 106.09% lower than that of the Health Care industry. The net income for all United States stocks is 100.75% higher than that of the company.
Aptorum Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aptorum Group's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aptorum Group could also be used in its relative valuation, which is a method of valuing Aptorum Group by comparing valuation metrics of similar companies.Aptorum Group is currently under evaluation in net income category among its peers.
Aptorum Group Institutional Holders
Institutional Holdings refers to the ownership stake in Aptorum Group that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Aptorum Group's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Aptorum Group's value.| Shares | Geode Capital Management, Llc | 2025-06-30 | 37.4 K | Advisor Group Holdings, Inc. | 2025-06-30 | 5.5 K | Citigroup Inc | 2025-06-30 | 995 | Sbi Securities Co Ltd | 2025-06-30 | 7.0 | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 0.0 | Susquehanna International Group, Llp | 2025-06-30 | 0.0 | Xtx Topco Ltd | 2025-06-30 | 0.0 | Ubs Group Ag | 2025-06-30 | 0.0 |
Aptorum Fundamentals
| Return On Equity | -0.14 | ||||
| Return On Asset | -0.0567 | ||||
| Current Valuation | 7.87 M | ||||
| Shares Outstanding | 6.35 M | ||||
| Shares Owned By Insiders | 16.40 % | ||||
| Shares Owned By Institutions | 0.13 % | ||||
| Number Of Shares Shorted | 3.03 K | ||||
| Price To Earning | 2.70 X | ||||
| Price To Book | 0.30 X | ||||
| Price To Sales | 23.35 X | ||||
| Gross Profit | 5.25 K | ||||
| EBITDA | (3.76 M) | ||||
| Net Income | (4.27 M) | ||||
| Cash And Equivalents | 4.22 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 3.35 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 1.14 X | ||||
| Book Value Per Share | 3.15 X | ||||
| Cash Flow From Operations | (1.19 M) | ||||
| Short Ratio | 0.06 X | ||||
| Earnings Per Share | (0.31) X | ||||
| Target Price | 80.0 | ||||
| Beta | -0.093 | ||||
| Market Capitalization | 6.37 M | ||||
| Total Asset | 16.13 M | ||||
| Retained Earnings | (72.43 M) | ||||
| Working Capital | (3.38 M) | ||||
| Current Asset | 25.7 M | ||||
| Current Liabilities | 10.9 M | ||||
| Net Asset | 16.13 M |
About Aptorum Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aptorum Group Ltd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aptorum Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aptorum Group Ltd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Will Biotechnology sector continue expanding? Could Aptorum diversify its offerings? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Aptorum Group data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Aptorum Group's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aptorum Group represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Aptorum Group's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.